Stevens-Johnson Syndrome (SJS) is a rare but serious disorder typically triggered by a medication or an infection. The condition causes a painful rash that spreads and blisters, eventually causing the top layer of skin to die, shed, and heal. When facing a diagnosis of SJS, understanding the treatment protocol is critical, as the approach focuses on immediate discontinuation of the culprit agent, supportive care, and mitigation of complications. The priority in the acute phase is to manage the symptoms and prevent further systemic damage, requiring a coordinated effort often involving dermatology, critical care, and pharmacy teams.
Immediate Withdrawal and Identification of the Trigger
The very first step in managing SJS is to identify and permanently stop the offending agent. In the majority of cases, this involves a specific antibiotic, anticonvulsant, or non-steroidal anti-inflammatory drug. Because the mortality and morbidity of the condition are directly linked to the speed of intervention, clinicians rely on validated diagnostic criteria to confirm the suspicion. Removing the trigger halts the ongoing immune-mediated attack on the skin and mucous membranes, which is essential to prevent progression from SJS to the more severe Toxic Epidermal Necrolysis (TEN). This step is straightforward in concept but complex in practice, as the reaction may occur days or weeks after starting the medication.
Supportive Care and Wound Management
Once the trigger is removed, the cornerstone of treatment shifts to aggressive supportive care. Because the epidermis is damaged, patients lose the protective barrier of their skin, leading to severe fluid loss, electrolyte imbalances, and hypothermia. Consequently, management often occurs in a burn unit or a specialized dermatology ward where strict environmental control is maintained. The skin care regimen involves gentle cleansing and the application of non-adherent, silicone-based dressings to protect the denuded areas. These dressings prevent friction, reduce pain, and create a moist environment that facilitates re-epithelialization without trapping bacteria.
Pain is a dominant feature of SJS, and managing it requires a multimodal approach. Standard analgesic protocols are often insufficient due to the severity of the burns-like wounds, necessitating the use of stronger analgesics or nerve blocks. Concurrently, the mucosal surfaces—such as the eyes, mouth, and genitalia—require specific attention. Ophthalmology consultation is crucial to prevent corneal scarring and vision loss, while oral care with saline rinses and topical analgesics helps maintain hydration and nutrition despite oral blistering.
Systemic Medications and Adjunctive Therapies
While supportive care is the foundation, the role of systemic immunomodulatory treatments remains a subject of ongoing clinical debate. Some centers administer high-dose intravenous immunoglobulin (IVIG), which works by neutralizing the antibodies that are attacking the skin cells. Studies suggest that IVIG can shorten the duration of the illness and reduce the need for mechanical ventilation in severe cases. Another option is the use of corticosteroids; however, their use is carefully weighed against the risk of infection, given the immunosuppressive effects of the drugs themselves.
In recent years, biological agents such as TNF-alpha inhibitors have been explored in refractory cases. These drugs target specific components of the immune system that drive the inflammatory cascade. Although not yet standardized as first-line therapy, they represent a promising avenue for patients who do not respond to conventional management. The selection of these advanced therapies depends heavily on the severity of the condition and the resources available at the treating institution.
Throughout the hospital stay, vigilant monitoring is required to catch complications early. The most significant risks include sepsis, pneumonia, and acute respiratory distress syndrome (ARDS). Because the mucosal barrier is compromised, bacteria can easily enter the bloodstream, leading to septic shock. Prophylactic antibiotics are generally avoided to prevent resistance, but clinicians maintain a high index of suspicion for infection. Serial examinations of the eyes are also performed to ensure that scarring does not lead to long-term visual impairment.
